Johnson FR - Search Results

1

Quantifying asthma patient preferences for onset of effect of combination inhaled corticosteroids and long-acting beta2-agonist maintenance medications.

Hauber AB, Mohamed AF, Johnson FR, Meddis D, Wagner S, O'Dowd L. Hauber AB, et al. Among authors: johnson fr. Allergy Asthma Proc. 2009 Mar-Apr;30(2):139-47. doi: 10.2500/aap.2009.30.3205. Allergy Asthma Proc. 2009. PMID: 19463204 Clinical Trial.

2

Risking health to avoid injections: preferences of Canadians with type 2 diabetes.

Hauber AB, Johnson FR, Sauriol L, Lescrauwaet B. Hauber AB, et al. Among authors: johnson fr. Diabetes Care. 2005 Sep;28(9):2243-5. doi: 10.2337/diacare.28.9.2243. Diabetes Care. 2005. PMID: 16123499 No abstract available.

3

Are chemotherapy patients' HRQoL importance weights consistent with linear scoring rules? A stated-choice approach.

Johnson FR, Hauber AB, Osoba D, Hsu MA, Coombs J, Copley-Merriman C. Johnson FR, et al. Qual Life Res. 2006 Mar;15(2):285-98. doi: 10.1007/s11136-005-0581-4. Qual Life Res. 2006. PMID: 16468083

4

Factors that affect adherence to bipolar disorder treatments: a stated-preference approach.

Johnson FR, Ozdemir S, Manjunath R, Hauber AB, Burch SP, Thompson TR. Johnson FR, et al. Med Care. 2007 Jun;45(6):545-52. doi: 10.1097/MLR.0b013e318040ad90. Med Care. 2007. PMID: 17515782

5

Older Americans' risk-benefit preferences for modifying the course of Alzheimer disease.

Hauber AB, Johnson FR, Fillit H, Mohamed AF, Leibman C, Arrighi HM, Grundman M, Townsend RJ. Hauber AB, et al. Among authors: johnson fr. Alzheimer Dis Assoc Disord. 2009 Jan-Mar;23(1):23-32. doi: 10.1097/WAD.0b013e318181e4c7. Alzheimer Dis Assoc Disord. 2009. PMID: 18725862

6

Benefits, risk, and uncertainty: preferences of antiretroviral-naïve African Americans for HIV treatments.

Hauber AB, Mohamed AF, Watson ME, Johnson FR, Hernandez JE. Hauber AB, et al. Among authors: johnson fr. AIDS Patient Care STDS. 2009 Jan;23(1):29-34. doi: 10.1089/apc.2008.0064. AIDS Patient Care STDS. 2009. PMID: 19113949

7

Who pays attention in stated-choice surveys?

Ozdemir S, Mohamed AF, Johnson FR, Hauber AB. Ozdemir S, et al. Among authors: johnson fr. Health Econ. 2010 Jan;19(1):111-8. doi: 10.1002/hec.1452. Health Econ. 2010. PMID: 19267358

8

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

Hauber AB, Mohamed AF, Johnson FR, Falvey H. Hauber AB, et al. Among authors: johnson fr. Diabet Med. 2009 Apr;26(4):416-24. doi: 10.1111/j.1464-5491.2009.02696.x. Diabet Med. 2009. PMID: 19388973

9

Hypothetical bias, cheap talk, and stated willingness to pay for health care.

Ozdemir S, Johnson FR, Hauber AB. Ozdemir S, et al. Among authors: johnson fr. J Health Econ. 2009 Jul;28(4):894-901. doi: 10.1016/j.jhealeco.2009.04.004. Epub 2009 Apr 18. J Health Econ. 2009. PMID: 19464743

10

Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome.

Lynd LD, Najafzadeh M, Colley L, Byrne MF, Willan AR, Sculpher MJ, Johnson FR, Hauber AB. Lynd LD, et al. Among authors: johnson fr. Value Health. 2010 Jun-Jul;13(4):411-7. doi: 10.1111/j.1524-4733.2009.00595.x. Epub 2009 Sep 10. Value Health. 2010. PMID: 19744297 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters